Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients

Kidney International

Volumn 54, Issue 4, 1998, Pages 1311-1319

  Pham, Hung Patrick ^b   Féray, Cyrille ^b   Samuel, Didier ^b   Gigou, Michèle ^b   Azoulay, Daniel ^b   Paradis, Valérie ^b   Ducret, Francis ^b   Charpentier, Bernard ^b   Debuire, Brigitte ^b   Lemoine, Antoinette ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b NONE

Author keywords

1 b D Ribofuranosyl 1,2,4 triazole 3 carboxamide; HCV; Hepatitis C virus; Membranoproliferative glomerulonephritis; MPGN; Reverse transcription polymerase chain reaction; Ribavirin; RT PCR

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MEFETIL; MYCOPHENOLIC ACID; RIBAVIRIN; UNCLASSIFIED DRUG;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CASE REPORT; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; FEMALE; GRAFT REJECTION; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME;

EID: 7344223860     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00113.x     Document Type: Article

References (22)

1. MISIANI R, BELLAVITA P, FENILI D, VICARI O, MARCHESI D, SIRONI PL, ZILIO P, VERNOCCHI A, MASSAZZA M, VENDRAMIN G, TANZI E, ZANETTI A: Interferon alpha 2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751-756, 1994
2. JOHNSON RJ, GRETCH DR, COUSER WG, ALPERS CE, WILSON J, CHANG M, HART J, WILSON R: Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 46:1700-1704, 1994
3. RAHAMIMOV R, ILAN Y, EID A, SHOUVAL D, TUR-KASPA R: Hepatitis C associated cryoglobulinemia after liver transplantation. Transplantation 60:1050-1051, 1995
4. GOURNAY J, FERRELL LD, ROBERTS JP, ASCHER NL, WRIGHT TL, LAKE JR: Cryoglobulinemia presenting after liver transplantation. Gastroenterology 110:265-270, 1996
5. FÉRAY C, GIGOU M, SAMUEL D, PARADIS V, WILBER J, DAVID MF, URDEA M, REYNÈS M, BRÉCHOT C, BISMUTH H: The course of hepatitis C virus infection after liver transplantation. Hepatology 20:1137-1143, 1994
6. KORAVIK J, MAYER G, POHANKA E, SCHWARTZ M, TRAINDL O, GRAF H, SMOLEN J: Adverse effect of low-dose prophylactic human recombinant interferon-alpha treatment in renal transplant recipients. Transplantation 45:402-405, 1988
7. FÉRAY C, SAMUEL D, GIGOU M, PARADIS V, DAVID MF, LEMONNIER C, REYNÈS M, BISMUTH H: An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 22:1084-1089, 1995
8. MUSSET L, DIEMERT MC, TAIBI F, THI HUONG DU L, CACOUB P, LEGER JM, BOISSY G, GAILLARD O, GALLI J: Characterization of cryoglobulins by immunoblotting. Clin Chem 38:798-802, 1992
9. BEDOSSA P, POYNARD T: An algorythm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289-293, 1996
10. SAMUEL D, BISMUTH A, MATHIEU D, ARULNADEN JL, REYNÈS M, BENHAMOU JP, BRECHOT C, BISMUTH H: Passive immunoprophylaxis after liver transplantation in HBs Ag positive patients. Lancet 337: 813-815, 1991
11. SAFADI R, SHOUVAL D, KASPA RT, ASHUR Y, HAN Y: Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation. Liver Transplant Surg 2:263-268, 1996
12. GARCIA G, SCULLARD G, SMITH C, WEISSBERG J, ALEXANDER S, ROBINSON WS, GREGORY P, MERIGAN TC: Preliminary observation of hepatitis B associated membranous glomerulonephritis after treated with leukocyte interferon. Hepatology 5:317-320, 1985
13. MIZUSHIMA N, KANAI K, MATSUDA H, MATSUMOTO M, TAMAKOSHI K, ISHII M, NAKAJIMAT T: Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology 92:524-526, 1987
14. DEMAN RA, SCHALM SW, VAN DER HEIJDEN AJ, TEN KATE FWJ, WOLFF ED, HEIJTINK RA: Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy. J Hepatol 111:479-483, 1989
15. LISKER-MELMAN M, WEBB D, DI BISCEGLIE AM, KASSIANIDES C, MARTIN P, RUSTGI V, WAGGONER JG, PARK Y, HOOFNAGLE JH: Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant alpha-interferon. Ann Intern Med 111: 479-483, 1989
16. STEHMAN-BREEN C, ALPERS CE, COUSER WG, WILLSON R, JOHNSON RJ: Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 44:141-147, 1995
17. DI BISCEGLIE AM, SHINDO M, FONG TL, FRIED MW, SWAIN MG, BERGASA NV, AXIOTIS CA, WAGGONER JG, PARK Y, HOOFNAGLE JH: A pilot study of rihavirin therapy for chronic hepatitis C. Hepatology 16:649-654, 1992
18. REICHARD O, YUN ZB, SÖNNERBORG A, WEILAND O: Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C. J Med Virol 41:99-102, 1993
19. BIZOLLON T, DUCERF C, TREPO C: New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin. J Hepatol 23:22-25, 1995
20. HEAGY W, CRUMPACKER C, LOPEZ PA, FINBERG RW: Inhibition of immune functions by antiviral drugs. J Clin Invest 87:1916-1924, 1991
21. DI MARTINO V, SAURINI F, SAMUEL D, GIGOU M, DUSSAIX E, REYNES M, BISMUTH H, FERAY C: Long term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 26:1343-1350, 1997
22. KAKUMU S, YOSHIOKA K, WAKITA T, ISHIKAWA T, TAKAYANAGI M, HIGASHI Y: A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 105:507-512, 1993